Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Kher

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|March 29, 2013
Tolvaptan in autosomal dominant polycystic kidney diseaseAjay Kher
Seminars in Nephrology|December 18, 2020
Prevention and Therapy of AKI in Asia: A Big ChallengeAjay Kher, Vijay Kher
Transplant International : Official Journal of the European Society for Organ Transplantation|April 12, 2019
Utility or futility of Interleukin 2 receptor antagonist (IL2RA) induction in kidney transplants-the devil is in the detailAjay Kher, Vijay Kher
The Medical Clinics of North America|June 19, 2012
Immunotherapy in renal diseasesAjay Kher, Vijay Kher
Seminars in Nephrology|October 16, 2012
Pre-emptive kidney transplantation to improve survival in patients with type 1 diabetes and imminent risk of ESRDMartha Pavlakis, Ajay Kher
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
The living kidney donor evaluation: focus on renal issuesAjay Kher, Didier A Mandelbrot
Transplantation|October 13, 2012
Reimbursement for living kidney donor follow-up care: how often does donor insurance pay?Ajay Kher, James Rodrigue, Maria Ajaimy, et al.
Surgical Infections|March 3, 2006
Disparate IL-1beta and iNOS gene expression in the aorta and pulmonary artery after endotoxemiaBen M Tsai, Meijing Wang, Jeffrey M Pitcher, et al.
Shock (Augusta, Ga.)|October 26, 2005
Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinoneBen M Tsai, Meijing Wang, Jeffrey M Pitcher, et al.
Cardiovascular Research|June 14, 2005
Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injuryAjay Kher, Kirstan K Meldrum, Meijing Wang, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|March 29, 2013
Tolvaptan in autosomal dominant polycystic kidney diseaseAjay Kher
Seminars in Nephrology|December 18, 2020
Prevention and Therapy of AKI in Asia: A Big ChallengeAjay Kher, Vijay Kher
Transplant International : Official Journal of the European Society for Organ Transplantation|April 12, 2019
Utility or futility of Interleukin 2 receptor antagonist (IL2RA) induction in kidney transplants-the devil is in the detailAjay Kher, Vijay Kher
The Medical Clinics of North America|June 19, 2012
Immunotherapy in renal diseasesAjay Kher, Vijay Kher
Seminars in Nephrology|October 16, 2012
Pre-emptive kidney transplantation to improve survival in patients with type 1 diabetes and imminent risk of ESRDMartha Pavlakis, Ajay Kher
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
The living kidney donor evaluation: focus on renal issuesAjay Kher, Didier A Mandelbrot
Transplantation|October 13, 2012
Reimbursement for living kidney donor follow-up care: how often does donor insurance pay?Ajay Kher, James Rodrigue, Maria Ajaimy, et al.
Surgical Infections|March 3, 2006
Disparate IL-1beta and iNOS gene expression in the aorta and pulmonary artery after endotoxemiaBen M Tsai, Meijing Wang, Jeffrey M Pitcher, et al.
Shock (Augusta, Ga.)|October 26, 2005
Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinoneBen M Tsai, Meijing Wang, Jeffrey M Pitcher, et al.
Cardiovascular Research|June 14, 2005
Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injuryAjay Kher, Kirstan K Meldrum, Meijing Wang, et al.
Pageof 3